BAIWANG CO(06657): Wang Qiangyu Appointed as Co-General Manager
BAIWANG CO(06657) announced that, after considering the recommendation of the board's nomination committee, the board has resolved to appoint Mr. Wang Qiangyu as co-general manager of the Company, with his primary responsibilities being to coordinate the Group's AI product strategic planning and the technical optimization, product iteration, scenario adaptation and full-chain commercialization implementation of fiscal and tax large models, promote the deep application of artificial intelligence technology in the enterprise services field and business innovation, and help the Company build a competitive AI product system, effective from September 14, 2026.
BAIWANG CO(06657) announced that, after considering the recommendation of the board's nomination committee, the board has resolved to appoint Mr. Wang Qiangyu as co-general manager of the Company, with primary responsibilities for overseeing the Group's AI product strategic planning and the technical optimization, product iteration, scenario adaptation, and full-chain commercialization of fiscal and tax large models, promoting the deep application of artificial intelligence technology in the enterprise services sector and business innovation, and helping the Company build a competitive AI product system, effective from September 14, 2026.
Related Articles

Hong Kong Stock Concept Tracker | AICC2026 Artificial Intelligence Computing Conference Will Be Held; Institutions Suggest Continued Focus on Computing Power Services, Domestic Chips, etc. (with Concept Stocks)

CUTIA-B(02487): CU-40102 (topical finasteride spray) receives marketing approval from the Pharmaceutical Administration Bureau of Macau

A-Share Subscription | Yute Optoelectronics (920157.BJ) Opens Subscription, Focused on R&D, Design, Precision Manufacturing, and Sales of Optical Connectivity Products
Hong Kong Stock Concept Tracker | AICC2026 Artificial Intelligence Computing Conference Will Be Held; Institutions Suggest Continued Focus on Computing Power Services, Domestic Chips, etc. (with Concept Stocks)

CUTIA-B(02487): CU-40102 (topical finasteride spray) receives marketing approval from the Pharmaceutical Administration Bureau of Macau

A-Share Subscription | Yute Optoelectronics (920157.BJ) Opens Subscription, Focused on R&D, Design, Precision Manufacturing, and Sales of Optical Connectivity Products

RECOMMEND





